PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
about
PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months
description
clinical trial
@en
klinisch onderzoek
@nl
name
PENTA15: Pharmacokinetic Study ...... Children Aged 3 to <36 Months
@en
type
label
PENTA15: Pharmacokinetic Study ...... Children Aged 3 to <36 Months
@en
prefLabel
PENTA15: Pharmacokinetic Study ...... Children Aged 3 to <36 Months
@en
P17
P1476
PENTA15: Plasma Pharmacokineti ...... on Aged 3 Months to <36 Months
@en
P1813
PENTA15
@en
P3098
NCT01973439
P4844
P580
2006-07-01T00:00:00Z
P582
2008-06-01T00:00:00Z